These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28866246)

  • 81. Von Hippel-Lindau syndrome and renal tumours: radiological diagnostic and treatment options. A case report and literature review.
    Untanas A; Trakymas M; Lekienė I; Briedienė R
    Acta Med Litu; 2020; 27(1):25-32. PubMed ID: 32577093
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes.
    Ramirez D; Ma YB; Bedir S; Antonelli JA; Cadeddu JA; Gahan JC
    J Endourol; 2014 Mar; 28(3):330-4. PubMed ID: 24156661
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
    Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
    Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.
    Jilg CA; Neumann HP; Gläsker S; Schäfer O; Ardelt PU; Schwardt M; Schultze-Seemann W
    Urol Int; 2012; 88(1):71-8. PubMed ID: 22156657
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: Case report and review of the literature.
    Addeo A; Bini R; Viora T; Bonaccorsi L; Leli R
    Int J Surg Case Rep; 2013; 4(8):648-50. PubMed ID: 23774333
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.
    Igarashi H; Esumi M; Ishida H; Okada K
    Cancer; 2002 Jul; 95(1):47-53. PubMed ID: 12115316
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
    Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
    Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients.
    Veltri A; De Fazio G; Malfitana V; Isolato G; Fontana D; Tizzani A; Gandini G
    Eur Radiol; 2004 Dec; 14(12):2303-10. PubMed ID: 15599549
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Natural history of Von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study.
    Wang J; Zhang L; Qiu J; Li Z; Wu Y; Zhang C; Yao L; Gong K; Li X; Zhou L
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2631-2641. PubMed ID: 34709473
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results.
    Su Li; Jarrett TW; Chan DY; Kavoussi LR; Solomon SB
    Urology; 2003 Apr; 61(4 Suppl 1):26-33. PubMed ID: 12657358
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer.
    Smits KM; Schouten LJ; Hudak E; Verhage B; van Dijk BA; Hulsbergen-van de Kaa CA; Goldbohm RA; Oosterwijk E; van den Brandt PA
    Ann Epidemiol; 2010 May; 20(5):401-4. PubMed ID: 20382342
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hereditary renal cancer patient and public involvement group: A collaborative, consensus decision process to develop a communication tool for patient use.
    Colvin E; Ng S; Hepworth J; Hepworth J; Hartley T; Godfrey N; Tricker K; Rothwell J; Beaman G; Woodward ER
    J Clin Transl Sci; 2023; 7(1):e115. PubMed ID: 37250990
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors.
    Suárez C; Vieito M; Valdivia A; González M; Carles J
    Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Oncological and Peri-Operative Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma for Patients with Hereditary RCC Diseases-An Analysis of European Multi-Centre Prospective EuRECA Registry.
    Osman FH; Chan VW; Breen DJ; King A; Nielsen TK; Garnon J; Alcorn D; Lagerveld B; Graumann O; Keeley FX; Walkden M; de Kerviler É; Wah TM
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444432
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
    Cinque A; Minnei R; Floris M; Trevisani F
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358771
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel-Lindau Disease-Results of a Prospective Trial.
    Kirste S; Rühle A; Zschiedrich S; Schultze-Seemann W; Jilg CA; Neumann-Haefelin E; Lo SS; Grosu AL; Kim E
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.